362 related articles for article (PubMed ID: 19639283)
1. Adenosine receptors and reperfusion injury of the heart.
Headrick JP; Lasley RD
Handb Exp Pharmacol; 2009; (193):189-214. PubMed ID: 19639283
[TBL] [Abstract][Full Text] [Related]
2. Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?
McIntosh VJ; Lasley RD
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):21-33. PubMed ID: 21335481
[TBL] [Abstract][Full Text] [Related]
3. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
Wan TC; Ge ZD; Tampo A; Mio Y; Bienengraeber MW; Tracey WR; Gross GJ; Kwok WM; Auchampach JA
J Pharmacol Exp Ther; 2008 Jan; 324(1):234-43. PubMed ID: 17906066
[TBL] [Abstract][Full Text] [Related]
4. Adenosine receptors and cancer.
Fishman P; Bar-Yehuda S; Synowitz M; Powell JD; Klotz KN; Gessi S; Borea PA
Handb Exp Pharmacol; 2009; (193):399-441. PubMed ID: 19639290
[TBL] [Abstract][Full Text] [Related]
5. Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes.
Wang J; Drake L; Sajjadi F; Firestein GS; Mullane KM; Bullough DA
Eur J Pharmacol; 1997 Feb; 320(2-3):241-8. PubMed ID: 9059860
[TBL] [Abstract][Full Text] [Related]
6. Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes.
Morrison RR; Teng B; Oldenburg PJ; Katwa LC; Schnermann JB; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1875-82. PubMed ID: 16679400
[TBL] [Abstract][Full Text] [Related]
7. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
8. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart.
Hill RJ; Oleynek JJ; Magee W; Knight DR; Tracey WR
J Mol Cell Cardiol; 1998 Mar; 30(3):579-85. PubMed ID: 9515033
[TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.
Cerniway RJ; Yang Z; Jacobson MA; Linden J; Matherne GP
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1751-8. PubMed ID: 11557567
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
11. Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: cardioprotection by activation of adenosine A(2A) receptors.
Maddock HL; Broadley KJ; Bril A; Khandoudi N
J Auton Pharmacol; 2001; 21(5-6):263-71. PubMed ID: 12123472
[TBL] [Abstract][Full Text] [Related]
12. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the heart.
Neely CF; DiPierro FV; Kong M; Greelish JP; Gardner TJ
Circulation; 1996 Nov; 94(9 Suppl):II376-80. PubMed ID: 8901778
[TBL] [Abstract][Full Text] [Related]
13. Adenosinergic cardioprotection: multiple receptors, multiple pathways.
Peart JN; Headrick JP
Pharmacol Ther; 2007 May; 114(2):208-21. PubMed ID: 17408751
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.
Koda K; Salazar-Rodriguez M; Corti F; Chan NY; Estephan R; Silver RB; Mochly-Rosen D; Levi R
Circulation; 2010 Aug; 122(8):771-81. PubMed ID: 20697027
[TBL] [Abstract][Full Text] [Related]
15. Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swine.
Long X; Mokelke EA; Neeb ZP; Alloosh M; Edwards JM; Sturek M
J Pharmacol Exp Ther; 2010 Dec; 335(3):781-7. PubMed ID: 20855445
[TBL] [Abstract][Full Text] [Related]
16. Adenosine: trigger and mediator of cardioprotection.
Cohen MV; Downey JM
Basic Res Cardiol; 2008 May; 103(3):203-15. PubMed ID: 17999026
[TBL] [Abstract][Full Text] [Related]
17. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
18. Anesthetic cardioprotection: the role of adenosine.
Bonney S; Hughes K; Eckle T
Curr Pharm Des; 2014; 20(36):5690-5. PubMed ID: 24502579
[TBL] [Abstract][Full Text] [Related]
19. Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning.
Guo Y; Bolli R; Bao W; Wu WJ; Black RG; Murphree SS; Salvatore CA; Jacobson MA; Auchampach JA
J Mol Cell Cardiol; 2001 Apr; 33(4):825-30. PubMed ID: 11273734
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.
Giannella E; Mochmann HC; Levi R
Circ Res; 1997 Sep; 81(3):415-22. PubMed ID: 9285644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
